Jury awards $289 million to man who said Roundup gave him cancer - WSFA.com Montgomery Alabama news.

Jury awards $289 million to man who said Roundup gave him cancer

Dewayne Johnson was diagnosed with non-Hodgkin's lymphoma in 2014. (Source: Josh Edelson/Pool Photo via AP, File) Dewayne Johnson was diagnosed with non-Hodgkin's lymphoma in 2014. (Source: Josh Edelson/Pool Photo via AP, File)

(RNN) – A jury has awarded $289 million to a man who claimed the weed killer Roundup gave him non-Hodgkin’s lymphoma.

Dewayne Johnson, 46, was a groundskeeper for the school district in Benicia, CA, north of San Francisco. He argued in court that years of using Roundup led him to being diagnosed with cancer in 2014.

On Friday, the jury sided with Johnson. They said Monsanto, an agribusiness giant known for its chemical products like Roundup and genetically modified organism (GMO) food products, such as seeds and crops, did not provide adequate warnings of Roundup’s risks.

The company, which was recently purchased by German pharmaceutical giant Bayer, had argued there weren’t any risks. After Friday’s verdict a company executive, Scott Partridge, maintained that glyphosate is “safe for use and does not cause cancer.”

In December, the Environmental Protection Agency concluded in a draft risk assessment that the pesticide glyphosate, the key ingredient in Roundup, was “not likely to be carcinogenic to humans.”

However the International Agency for Research on Cancer, a division of the World Health Organization, said in a 2015 report that it was “probably carcinogenic to humans.”

According to CNN, Monsanto faces thousands more similar suits from non-Hodgkin’s lymphoma patients.

“The jury found Monsanto acted with malice and oppression because they knew what they were doing was wrong and doing it with reckless disregard for human life,” one of Johnson’s attorneys, Robert F. Kennedy Jr., said.

In court, Johnson’s lawyers said his industrial use of Roundup resulted in frequent bodily contact, including at least two work accidents in which he was covered with the chemical.

They said he even once contacted Monsanto after developing a rash, and wasn’t told of any risk, the AP reported.

Since contracting non-Hodgkin’s lymphoma, Johnson has developed lesions all over his body and sometimes struggles to speak. One of his lawyers said “it’s just a matter of time” until he dies.

Johnson had sought more than $400 million in the case. Monsanto said it will appeal.

 Johnson has two children and a wife, Araceli, who now works two jobs to take care of the family.

Copyright 2018 Raycom News Network. All rights reserved.

  • Latest health & fitness newsLatest health & fitness newsMore>>

  • Synthetic pot seen as a public health danger

    Synthetic pot seen as a public health danger

    Friday, August 17 2018 12:35 PM EDT2018-08-17 16:35:48 GMT
    Saturday, August 18 2018 8:11 PM EDT2018-08-19 00:11:39 GMT
    (Brian A. Pounds/Hearst Connecticut Media via AP). FILE - In this Thursday, Aug. 16, 2018 file photo, paramedics and EMT members respond to one of three simultaneous drug overdose victims on the New Haven Green, a city park in New Haven, Conn. Police s...(Brian A. Pounds/Hearst Connecticut Media via AP). FILE - In this Thursday, Aug. 16, 2018 file photo, paramedics and EMT members respond to one of three simultaneous drug overdose victims on the New Haven Green, a city park in New Haven, Conn. Police s...
    What is synthetic marijuana and why is it so dangerous?.More >>
    What is synthetic marijuana and why is it so dangerous?.More >>
  • Multi-gene test may find risk for heart disease and more

    Multi-gene test may find risk for heart disease and more

    Monday, August 13 2018 2:24 PM EDT2018-08-13 18:24:18 GMT
    Saturday, August 18 2018 8:11 PM EDT2018-08-19 00:11:36 GMT
    New way to track millions of genetic variations promises better forecasting of people's risk for heart attacks, four other disorders.More >>
    New way to track millions of genetic variations promises better forecasting of people's risk for heart attacks, four other disorders.More >>
  • US approves new generic competitor to EpiPen

    US approves new generic competitor to EpiPen

    Thursday, August 16 2018 3:47 PM EDT2018-08-16 19:47:00 GMT
    Saturday, August 18 2018 8:11 PM EDT2018-08-19 00:11:34 GMT
    The new generic version will be sold by Teva Pharmaceuticals. (Source: AP Photo/Rich Pedroncelli, File)The new generic version will be sold by Teva Pharmaceuticals. (Source: AP Photo/Rich Pedroncelli, File)

    US officials approves new generic competitor for emergency allergy medication EpiPen.

    More >>

    US officials approves new generic competitor for emergency allergy medication EpiPen.

    More >>
Powered by Frankly